// App-Quantinova.ai

OP0286 (2021) : CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA)

Researchers

Presenter

  • M. F. Ugarte-Gil

Principal Investigators

  • A. Seet

  • Z. Izadi

  • C. Reategui Sokolova

  • A. E. Clarke

  • G. Pons-Estel

  • M. J. Santos

  • S. Bernatsky

  • N. Lim

  • J. Sparks

  • Z. Wallace

  • K. Hyrich

  • A. Strangfeld

  • L. Gossec

  • L. Carmona

  • E. Mateus

  • S. Lawson-Tovey

  • L. Trupin

  • G. Schmajuk

  • P. Katz

  • L. Jacobsohn

  • S. Al Emadi

  • E. Gilbert

  • A. Duarte-Garcia

  • M. Valenzuela-Almada

  • T. Hsu

  • K. Dsilva

  • P. Dieud

  • E. Nikiphorou

  • V. Kronzer

  • N. Singh

  • A. Akpabio

  • R. Thomas

  • S. Bhana

  • W. Costello

  • R. Grainger

  • J. Hausmann

  • J. Liew

  • E. Sirotich

  • P. Sufka

  • P. Robinson

  • P. Machado

  • M. Gianfrancesco

  • J. Yazdany

Medical Centers

  • Universidad Cientifica del Sur, School of Medicine, Lima, Peru

  • Hospital Nacional Guillermo Almenara Essalud, Rheumatology, Lima, Peru

  • U of Alabama at Birmingham, Dept of Medicine, Birmingham, AL, United States of America

  • Universidad Peruana Cayetano Heredia, School of Medicine, Lima, Peru

  • University of California Los Angeles, Division of Rheumatology, Department of Medicine, Los Angeles, CA, United States of America

  • University of California, San Francisco, Department of Epidemiology and Biostatistics, San Francisco, United States of America

  • Universidad San Ignacio de Loyola, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Lima, Peru

  • Cumming School of Medicine. University of Calgary, Division of Rheumatology Department of Medicine, Calgary, Canada

  • University of California Los Angeles, Division of Rheumatology, Department of Medicine, Los Angeles, CA, United States of America

  • Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina

  • Instituto de Medicina Molecular, Faculdade de Lisboa, Rheumatology Department, Hospital Garcia de Orta, Almada and Rheumatology Research Unit, Lisbon, Portugal

  • McGill University Health Centre, Divisions of Rheumatology and Clinical Epidemiology, Quebec, Canada

  • Brigham and Women’s Hospital and Harvard Medical School, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, United States of America

  • Massachusetts General Hospital, Harvard Medical School, Clinical Epidemiology Program and Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Boston, United States of America

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • German Rheumatism Research Centre, Epidemiology and Health Care Research, Berlin, Germany

  • Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé Publique, PEPITES, Paris, France

  • Instituto de Salud Musculoesquelética, Instituto de Salud Musculoesquelética, Madrid, Spain

  • Portuguese League Against Rheumatic Diseases (LPCDR), Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal

  • Hamad Medical Corporation, Medicine/Rheumatology, Doha, Qatar

  • Mayo Clinic, Division of Rheumatology, Jacksonville, Florida, United States of America

  • Mayo Clinic, Division of Rheumatology and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota, United States of America

  • Mayo Clinic, Division of Rheumatology, Rochester, Minnesota, United States of America

  • Brigham and Women’s Hospital and Harvard Medical School, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, United States of America

  • Massachusetts General Hospital, Harvard Medical School, Clinical Epidemiology Program and Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Boston, United States of America

  • Massachusetts General Hospital, Harvard Medical School, Clinical Epidemiology Program and Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Boston, United States of America

  • Hôpital Cochin, AP-HP, Rheumatology, Paris, France

  • King’s College London, Centre for Rheumatic Disease, London, United Kingdom

  • Mayo Clinic, Rheumatology, Rochester, MN, United States of America

  • University of Washington, Division of Medical Genetics, Seattle, United States of America

  • University of Michigan, Department of Internal Medicine/Rheumatology, Michigan, United States of America

  • University of Uno Teaching Hospital, Rheumatology, Uyo, Nigeria

  • University of Queensland Diamantina Institute, Brisbane, Australia

  • Crystal Run Health, Crystal Run Health, Middletown, NY, United States of America

  • Irish Children’s Arthritis Network (iCAN), Irish Children’s Arthritis Network (iCAN), Ireland

  • University of Otago, Department of Medicine, Dunedin, New Zealand

  • Beth Israel Deaconess Medical Center, Harvard Medical School, Program in Rheumatology, Boston Children’s Hospital; Division of Rheumatology and Clinical Immunology, Boston, MA, United States of America

  • George Washington University School of Medicine, Department of Medicine, Washington, DC, United States of America

  • McMaster University, Department of Health Research Methods, Evidence and Impact, Department of Medicine, Hamilton, Canada

  • Healthpartners, St. Paul, MN, United States of America

  • University of Queensland, Faculty of Medicine, Brisbane, United States of America

  • University College London, Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, London, United Kingdom

Locations

  • Peru

  • United States

  • Canada

  • Argentina

  • Portugal

  • United Kingdom

  • Germany

  • France

  • Spain

  • Qatar

  • Nigeria

  • Australia

  • Ireland

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Lupus

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved